RNA vaccines train the immune system in a similar way to traditional vaccines, but they use a different strategy to get there ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

Three Johns Hopkins experts discuss the potential of mRNA-powered therapeutics to produce lifesaving treatments and cures for ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

Researchers from the International Institute of Molecular and Cell Biology in Warsaw (IIMCB) have described a new mechanism ...

Researchers working on mRNA vaccines fear federal funding might be halted, with many looking to move projects abroad ...

Experimental mRNA Cancer Vaccine Shows Potential for Advanced Stage Cancer Patients in Phase 1 Trial Sep. 13, 2024 — Interim data from the Phase I dose escalation part of the mRNA cancer ...

New melanoma skin cancer cases are set to increase from 20,800 cases in the 2023 to 2025 period, to an average of 26,500 ...

HONG KONG SAR - Newswire - 11 April 2025 - CK Life Sciences Int'l., (Holdings) Inc. ("CK Life Sciences"), a leader in cancer ...

Patients with an advanced type of skin melanoma in England will be given expedited access to a new vaccine being developed by Scancell as part of a National Health Service (NHS) clinical trial.

This initiative is part of the NHS Cancer Vaccine Launch Pad (CVLP), a program designed to fast-track access to mRNA vaccine clinical trials for various cancer types. Building on its success in ...

“MRNA technology is used for many things, not just infectious disease vaccines. There are cancer therapies that are being developed,” he added. “There’s gene editing and gene therapies tha ...